Biomarker
Anderson KG, Ribas A. Neoadjuvant PD-1 blockade: a new treatment option for patients with early-stage mismatch repair deficient solid tumors. J Immunother Cancer. 2025 Aug[...]
Singal AG, Quirk L, Boike J, Chernyak V, Feng Z, Giamarqo G, Kanwal F, Ioannou GN, Manes S, Marrero JA, Mehta N, Pillai A, Shaheen[...]
Yen YT, Zhao C, Gao T, Yang JZ, Kang N, Pu J, Qiu L, Hu Q, Kim H, Wang A, Lee J, Zhang RY, Liu[...]
Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi[...]
Alsoud D, Noor NM, Chen LA, Abadom V, Anderson SHC, Ardolli L, Axelrad J, Bossuyt P, Croitoru K, Damas OM, Deng L, Deepak P, Negro[...]
Zong NC, Huang K, Yang X, Cai H. Expand the success of screening to reduce aortic aneurysm mortality: progress interpretation and new fronts. Trends Cardiovasc[...]
Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi[...]
Talukder R, Bakaloudi DR, Makrakis D, Diamantopoulos LN, Enright T, Leary JB, Raychaudhuri R, Tripathi N, Agarwal N, Jindal T, Brown JR, Zakharia Y, Rey-Cárdenas[...]
Hsu FM, Mohanty RP, Rubbi L, Thompson M, Pickering H, Reed EF, Greenland JR, Schaenman JM, Pellegrini M. An epigenetic human cytomegalovirus infection score predicts[...]
Jilg N, Giganti MJ, Chew KW, Shaw-Saliba K, Ritz J, Moser C, Evering TH, Daar ES, Eron JJ, Currier JS, Hughes MD, Lane HC, Dewar[...]